You are here: Industry Insights > Market News

News List

Touchlight Introduces mbDNA™: A “Best-In-Class" Circular Single Stranded DNA (ssDNA) Platform Enabling Superior Gene Editing Biotech Newswire
July 30, 2025
Touchlight, a pioneer in cell-free DNA innovation, is proud to announce the commercial launch of their new technology for non-viral gene editing, mbDNA™.
Telix H1 2025 Results: Investor Webcast Notification PR Newswire
July 30, 2025
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today advises that it will release its financial results for the half-year ended 30 June 2025 on Thursday 21 August 2025.
Vexev and U.S. Renal Care Complete Enrollment in Groundbreaking Trial Evaluating Use of Robotic Ultrasound Scanning for AV Fistula Mapping in Dialysis Clinics PR Newswire
July 30, 2025
CANSCAN study enrolled 120 patients with chronic kidney disease using the investigational, semi-autonomous VxWave™ Ultrasound Imaging System
Alamar Biosciences and the German Center for Neurodegenerative Diseases (DZNE) Partner for Landmark Proteomic Profiling Study in the Rhineland Study Cohort PR Newswire
July 29, 2025
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced a strategic collaboration with the German Center for Neurodegenerative Diseases.
Leo Cancer Care Receives FDA 510(k) Clearance for Marie® - A Revolutionary Upright Radiotherapy Platform PR Newswire
July 29, 2025
Leo Cancer Care, a leader in upright radiotherapy solutions, today announces that its flagship product, Marie®, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Tigermed Completes Acquisition of Japanese CRO Micron PRNewswire
July 29, 2025
Tigermed (300347.SZ / 3347.HK), a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical and medical device products, today announces the completion of its acquisition of CRO company Micron,Inc.
Alphamab Oncology Announces Anti-HER2 Biparatopic ADC JSKN003 Obtained Orphan Drug Designation from the U.S. FDA for the Treatment of GC/GEJ PR Newswire
July 29, 2025
Alphamab Oncology announced that anti-HER2 biparatopic antibody-drug conjugate JSKN003 has been granted Orphan Drug Designation by the FDA for the treatment of gastric cancer and gastroesophageal junction cancer (GC/GEJ).
Everest Medicines Announces Share Placement to Raise Approximately HK$1,572.50 Million ACN Newswire
July 25, 2025
Everest Medicines, together with its controlling shareholder CBC Group and the placing agents, entered into a placing and subscription agreement for the sale of 22,561,000 shares at a purchase price of HK$69.70 per share.
Multi-Dose Diquafosol Sodium Eye Drops Obtained Approval from NMPA for Commercialisation in China ACN Newswire
July 25, 2025
Essex Bio-Technology Limited is pleased to announce that an indirect wholly-owned subsidiary, has received approval from AMPA for the registration and commercialisation of the multi-dose Diquafosol Sodium Eye Drops in the PRC.
Avantor Relocates Korea Office in Suwon to Support Growth and Enhance Collaboration ACN Newswire
July 24, 2025
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, has inaugurated its new office in Suwon, Korea.